Universal Biosensors Inc UBI
We take great care to ensure that the data presented and summarized in this overview for UNIVERSAL BIOSENSORS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in UBI
Top Purchases
Top Sells
About UBI
Insider Transactions at UBI
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 27
2024
|
Graham A Mc Lean Director |
BUY
Grant, award, or other acquisition
|
Indirect |
275,000
+20.29%
|
$0
$0.11 P/Share
|
|
May 27
2024
|
John Stewart Sharman Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
275,000
+14.98%
|
$0
$0.11 P/Share
|
|
May 27
2024
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
1,421,293
+1.6%
|
$0
$0.11 P/Share
|
|
May 01
2024
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
29,506,606
+21.83%
|
$0
$0.15 P/Share
|
|
May 01
2024
|
Graham A Mc Lean Director |
BUY
Grant, award, or other acquisition
|
Indirect |
180,116
+18.28%
|
$0
$0.15 P/Share
|
|
May 01
2024
|
Judith Ann Smith Director |
BUY
Grant, award, or other acquisition
|
Indirect |
99,077
+18.28%
|
$0
$0.15 P/Share
|
|
May 01
2024
|
John Stewart Sharman Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
40,000
+3.92%
|
$0
$0.15 P/Share
|
|
May 01
2024
|
John Stewart Sharman Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,055
+18.28%
|
$0
$0.15 P/Share
|
|
Mar 25
2024
|
John Stewart Sharman Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000,000
-92.59%
|
-
|
|
Mar 25
2024
|
John Stewart Sharman Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
1,000,000
+43.93%
|
-
|
|
Mar 25
2024
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+1.73%
|
$0
$0.2 P/Share
|
|
Mar 25
2024
|
John Stewart Sharman Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,364,666
+48.58%
|
$0
$0.2 P/Share
|
|
Dec 11
2023
|
Graham A Mc Lean Director |
BUY
Grant, award, or other acquisition
|
Indirect |
75,000
+10.71%
|
$0
$0.2 P/Share
|
|
Sep 11
2023
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+11.71%
|
$0
$0.22 P/Share
|
|
Jun 30
2023
|
David L Hoey Director |
BUY
Open market or private purchase
|
Direct |
95,983
+12.66%
|
$0
$0.17 P/Share
|
|
Mar 14
2023
|
Graham A Mc Lean Director |
BUY
Grant, award, or other acquisition
|
Indirect |
150,000
+21.43%
|
$0
$0.25 P/Share
|
|
Jan 01
2023
|
Salesh Balak Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+11.4%
|
-
|
|
Jan 01
2023
|
John Stewart Sharman Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+38.46%
|
-
|
|
Dec 12
2022
|
Graham A Mc Lean Director |
BUY
Grant, award, or other acquisition
|
Indirect |
200,000
+33.33%
|
$0
$0.23 P/Share
|
|
Nov 16
2022
|
Craig E. Coleman Director |
BUY
Open market or private purchase
|
Indirect |
17,848
+2.66%
|
$0
$0.24 P/Share
|
Last 12 Months Summary
Buy / Acquisition
35.2M
Shares
From
6
Insiders
| Open market or private purchase | 31.9M shares |
|---|---|
| Grant, award, or other acquisition | 892K shares |
| Bona fide gift | 1M shares |
| Exercise of conversion of derivative security | 1.36M shares |
Sell / Disposition
1M
Shares
From
1
Insiders
| Bona fide gift | 1M shares |
|---|